41 – 50 of 67
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Reprogramming primary melanoma cells to dendritic cell fate enhances tumor immunogenicity
(2022) SITC Society for Immunotherapy of Cancer 2022
- Contribution to conference › Poster
-
Mark
Restoring tumor immunogenicity with dendritic cell reprogramming
- Contribution to journal › Published meeting abstract
-
Mark
Direct Reprogramming of Mouse and Human Fibroblasts into Conventional Dendritic Cells Type 1
- Contribution to journal › Published meeting abstract
-
Mark
Eliciting Anti-Tumor Immunity by Reprogramming Cancer Cells to Type 1 Conventional Dendritic Cells
(2022) European Association for Cancer Research 2022 - Congress
- Contribution to conference › Poster
-
Mark
Harnessing Dendritic Cell Reprogramming to Elucidate Mechanisms of Tumor Immunity
(2022) Lund Stem Cell Center Retreat
- Contribution to conference › Poster
- 2021
-
Mark
Cell Fate Reprogramming in the Era of Cancer Immunotherapy
- Contribution to journal › Scientific review
-
Mark
Generating Dendritic Cells by Direct Cell Reprogramming. Merging cellular reprogramming with immunology towards the development of novel cancer immunotherapies.
(2021) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
Identification of potential chemical compounds enhancing generation of enucleated cells from immortalized human erythroid cell lines
- Contribution to journal › Article
-
Mark
Ontogenic shifts in cellular fate are linked to proteotype changes in lineage-biased hematopoietic progenitor cells
- Contribution to journal › Article
-
Mark
Reprogramming Stars #1 : Genome Programming through the Cell Cycle - An Interview with Dr. Tomomi Tsubouchi
- Contribution to journal › Debate/Note/Editorial
